Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Survivors: Exercise and Raloxifene

NCT00031811 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT00031811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00031811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Survivors: Exercise and Raloxifene
Lead sponsor
OHSU Knight Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2001
Completion date
April 30, 2003
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, menopausal symptoms, osteoporosis